Shijiazhuang Yiling Pharmaceutical Co., Ltd.

¥16.05As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002603Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 4.89%
Div yield 4.98%
ROE 12.59%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.41
PE TTM 19.40
TSR TTM (7.33%)
Mkt cap ¥26.81B
ROIC 15.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥20
24.81%
24.49%
Sell 3|4|2|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.17
0.16
0.16
4.12%
2.33%
(9.48%)
(11.27%)
Revenue¥B
1.493
1.464
1.465
1.433
5.80%
(0.59%)
(1.29%)
(1.71%)
Peers (US$4.020B)
Cap (US$)
PE
3.934B
28.04x
3.974B
30.04x
Capital
TTM
5Y
10Y
Leveragex
0.275
—
—
EBIT/Intx
1.273
0.117
0.114
Own earn%
180.61
(28.60)
(37.18)
Sh yield%
25.60
7.93
8.60
Owners
Insiders/Inst%
8.68
84.79
Short interest%
1.46
SBC / revenue%
4.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
1